Research / MDB / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-26-039150 General Corporate
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.34% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
29.32% · OPTIONAL · VALID
Revenue growth 40th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
25.25% · CORE · VALID
Gross margin 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
72.16% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-3.61% · CORE · VALID
R&D intensity 15th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
29.15% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
20.04% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 29 states Self-history eligible
Jul 31, 2021 6/7 normalized Level 3 Oct 31, 2021 6/7 normalized Level 3 Jan 31, 2022 6/7 normalized Level 3 Apr 30, 2022 7/7 normalized Level 3 Jul 31, 2022 7/7 normalized Level 3 Oct 31, 2022 7/7 normalized Level 3 Jan 31, 2023 7/7 normalized Level 3 Apr 30, 2023 7/7 normalized Level 3 Jul 31, 2023 7/7 normalized Level 3 Oct 31, 2023 7/7 normalized Level 3 Jan 31, 2024 7/7 normalized Level 3 Apr 30, 2024 7/7 normalized Level 3 Jul 31, 2024 7/7 normalized Level 3 Oct 31, 2024 7/7 normalized Level 3 Jan 31, 2025 7/7 normalized Level 3 Apr 30, 2025 7/7 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 0.20%
Current 0.34%
Delta 0.14% Cash Generation Increased
Previous 20.50%
Current 29.32%
Delta 8.82% Growth Increased
Previous 22.79%
Current 25.25%
Delta 2.45% Margin Increased
Previous 71.75%
Current 72.16%
Delta 0.41% Profitability Increased
Previous -5.56%
Current -3.61%
Delta 1.95% R And D Intensity Increased
Previous 29.07%
Current 29.15%
Delta 0.07% Sbc Intensity Decreased
Previous 22.34%
Current 20.04%
Delta -2.30% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Jan 31, 2026
Similarity 91%
Compared 7 dimensions
Coverage 100% Growth 10.0 · Margin 5.0 · Profitability 5.0 · Sbc Intensity 5.0 · Capex Intensity 20.0 · Cash Generation 5.0 · R And D Intensity 5.0 Apr 30, 2025
Similarity 85%
Compared 7 dimensions
Coverage 100% Growth 30.0 · Margin 5.0 · Profitability 0.0 · Sbc Intensity 10.0 · Capex Intensity 20.0 · Cash Generation 0.0 · R And D Intensity 10.0 Oct 31, 2024
Similarity 78%
Compared 7 dimensions
Coverage 100% Growth 34.4 · Margin 35.0 · Profitability 5.0 · Sbc Intensity 15.0 · Capex Intensity 10.0 · Cash Generation 20.0 · R And D Intensity 15.0 Jan 31, 2024
Similarity 71%
Compared 7 dimensions
Coverage 100% Growth 26.7 · Margin 39.5 · Profitability 5.5 · Sbc Intensity 52.6 · Capex Intensity 24.2 · Cash Generation 10.5 · R And D Intensity 4.5 Apr 30, 2023
Similarity 64%
Compared 7 dimensions
Coverage 100% Growth 40.0 · Margin 50.0 · Profitability 5.0 · Sbc Intensity 56.3 · Capex Intensity 40.0 · Cash Generation 0.0 · R And D Intensity 15.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.